News | January 31, 2014

Gore, AAAneurysm Outreach to Increase Early Detection of Abdominal Aortic Aneurysm

Campaign focuses on awareness, community outreach, patient screening

Gore AAAneurysm Outreach Abdominal Aortic Aneurysm AAA Stent Graphs

January 31, 2014 — W. L. Gore & Associates Inc. (Gore) and AAAneurysm Outreach have partnered to raise awareness and drive screening of individuals at-risk of abdominal aortic aneurysm (AAA). The organizations aim to increase programming and education for clinicians and those at risk of AAA, a potentially life-threatening condition caused by a balloon-like of the abdominal aorta.
 
The partnership and resulting campaign will focus on three key initiatives: awareness, outreach and screening. Raising awareness of AAA through community engagement is a cornerstone of both AAAneurysm Outreach’s approach and Gore’s commitment to patient and clinical groups. AAAneurysm Outreach and Gore will launch an AAA Community Speaker Series where survivors, advocates, providers and at-risk individuals will share experiences and examine issues related to AAA.
 
Through outreach efforts, Gore and AAAneurysm Outreach will provide materials intended to enhance primary care physicians’ understanding of AAA diagnosis and treatment. The campaign will provide primary care physicians with toolkits to support interaction and communication with vascular surgeons, interventional cardiologists and radiologists within their region.
 
Finally, the campaign will organize and conduct AAA screenings for those at risk. A key element of this effort will include the AAA Screening Tour, which will empower the patient community to understand risks and facts about AAA. Collaborating with regional healthcare providers, the organizations aim to screen up to 300 individuals at each event.
 
At-risk individuals include those over the age of 60, those with a history of smoking and those with a family history of AAA. 
 
For more information: www.aoutreach.org, www.gore.com

Related Content

News | Stent Grafts

April 26, 2023 — Medtronic today announced its Endurant abdominal aortic aneurysm (AAA) stent graft system continues to ...

Home April 26, 2023
Home
News | Stent Grafts

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

Home January 12, 2023
Home
News | Stent Grafts
May 4, 2022 – Seeking to bolster its development of a biocompatible graft that promises to reshape the future of cardiac ...
Home May 04, 2022
Home
News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
News | Stent Grafts

October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...

Home October 08, 2019
Home
News | Stent Grafts

July 10, 2019 — W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable ...

Home July 10, 2019
Home
Technology | Stent Grafts

May 15, 2019 — W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted ...

Home May 15, 2019
Home
News | Stent Grafts

February 14, 2019 — Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft ...

Home February 14, 2019
Home
Technology | Stent Grafts

February 7, 2019 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant ...

Home February 07, 2019
Home
News | Stent Grafts

January 7, 2019 — Endologix Inc. announced that in order to ensure optimal outcomes for patients, unrestricted sales and ...

Home January 07, 2019
Home
Subscribe Now